Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Publish
Dashboard
Subscribe to $RCOR
Renovacor Inc.
Subscribe to $RCOR
$RCOR
Biotechnology: Pharmaceutical Preparations
Health Care
IPO Year: 2020
Exchange: AMEX
Recent Analyst Ratings for Renovacor Inc.
Date
Price Target
Rating
Analyst
9/13/2022
$9.00
Outperform
Robert W. Baird
10/14/2021
$22.00
Buy
Ladenburg Thalmann
10/1/2021
$20.00
Buy
Chardan Capital Markets
See more ratings
